The Effectiveness of BCG (Bacillus-Calmette Guerin) Immunization to the Tuberculosis Incidence on Children at Banyuasin Regency
Bacillus Calmette Guerin (BCG) vaccine is still the only licensed vaccine against Tuberculosis (TB), with an estimated global coverage of 85%. However, although the vaccine has been established, discussions about its benefits and shortcomings continue.The coverage of immunization is appropriate with...
Main Authors: | Wulanda Ayu Febri, Sitorus Rico Januar, Zulkarnain |
---|---|
Format: | Article |
Language: | English |
Published: |
EDP Sciences
2018-01-01
|
Series: | E3S Web of Conferences |
Online Access: | https://doi.org/10.1051/e3sconf/20186801013 |
Similar Items
-
Bacillus Calmette-Guerin (BCG): the adroit vaccine
by: Oluwafolajimi A. Adesanya, et al.
Published: (2021-02-01) -
Disseminated Bacillus Calmette-Guérin (BCG) infections in infants with immunodeficiency
by: Suleiman Al-Hammadi, et al.
Published: (2017-05-01) -
Bacillus Calmette-Guérin (BCG) Brazilian Backstage in Bladder Cancer
by: Fernando Korkes, et al.
Published: (2021-02-01) -
Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer's disease in bladder cancer patients.
by: Ofer N Gofrit, et al.
Published: (2019-01-01) -
The impact of Bacillus Calmette-Guérin (BCG) vaccination on the course of COVID-19
by: Jakub Krzysztof Gałązka
Published: (2022-10-01)